Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 1 |
2018 | 1 |
2020 | 1 |
2021 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial.
BMC Womens Health. 2021 Oct 28;21(1):375. doi: 10.1186/s12905-021-01475-2.
BMC Womens Health. 2021.
PMID: 34711224
Free PMC article.
Clinical Trial.
Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study.
Osuga Y, Seki Y, Tanimoto M, Kusumoto T, Kudou K, Terakawa N.
Osuga Y, et al. Among authors: seki y.
Fertil Steril. 2021 Feb;115(2):397-405. doi: 10.1016/j.fertnstert.2020.07.055. Epub 2020 Sep 7.
Fertil Steril. 2021.
PMID: 32912633
Free article.
Clinical Trial.
Item in Clipboard
Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results.
Osuga Y, Seki Y, Tanimoto M, Kusumoto T, Kudou K, Terakawa N.
Osuga Y, et al. Among authors: seki y.
BMC Womens Health. 2021 Jun 21;21(1):250. doi: 10.1186/s12905-021-01393-3.
BMC Womens Health. 2021.
PMID: 34154590
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: An open-label, phase 3 exploratory study.
Inagaki N, Sano H, Seki Y, Kuroda S, Kaku K.
Inagaki N, et al. Among authors: seki y.
J Diabetes Investig. 2018 Mar;9(2):354-359. doi: 10.1111/jdi.12730. Epub 2017 Oct 30.
J Diabetes Investig. 2018.
PMID: 28836351
Free PMC article.
Clinical Trial.
Item in Clipboard
Long-term safety and efficacy of a novel once-weekly oral trelagliptin as monotherapy or in combination with an existing oral antidiabetic drug in patients with type 2 diabetes mellitus: A 52-week open-label, phase 3 study.
Inagaki N, Sano H, Seki Y, Kuroda S, Kaku K.
Inagaki N, et al. Among authors: seki y.
J Diabetes Investig. 2016 Sep;7(5):718-26. doi: 10.1111/jdi.12499. Epub 2016 Mar 28.
J Diabetes Investig. 2016.
PMID: 27181699
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite